Methyl iodide → HCID 118133429, compound
Reaction equation
[CH3:1][C@@H:2]1[C@H:7]([N:8]2[CH2:12][CH2:11][NH:10][C:9]2=[O:13])[CH2:6][CH2:5][CH2:4][N:3]1[C:14]([O:16][CH2:17][C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1)=[O:15].[H-].[Na+].I[CH3:27]>C1COCC1.CCOC(C)=O.O>[CH3:1][C@@H:2]1[C@H:7]([N:8]2[CH2:12][CH2:11][N:10]([CH3:27])[C:9]2=[O:13])[CH2:6][CH2:5][CH2:4][N:3]1[C:14]([O:16][CH2:17][C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1)=[O:15]Participants
Procedure
Compound 354 (490 mg, 1.55 mmol) was dissolved in 15 mL dry THF. It was treated with NaH (60% in mineral oil, 125 mg, 3.1 mmol) for 15 min at RT. To the mixture was then added iodomethane (200 μL, 3.1 mmol). The mixture was stirred at RT for 1.5 hour, diluted with 150 mL EtOAc and 50 water. The organic phase was separated, washed with water, dried, concentrated, and subjected to silica flash column using 0 to 4% MeOH in DCM to isolate (2R,3R)-benzyl 2-methyl-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidine-1-carboxylate (355, 470 mg, 92%). It was dissolved in 100 mL iPrOH. To it was added 10% Pd/C (0.5 g), and the mixture was hydrogenated at 40 psi on a Parr shaker for overnight. The mixture was filtered through celite and concentrated in vacuo to give 1-methyl-3-((2R,3R)-2-methylpiperidin-3-yl)imidazolidin-2-one (356) as a white solid in quantitative yield.
Workup
- customThe organic phase was separated
- washwashed with water
- customdried
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-b72453bce6f64c1c84fe8fd2a230749f
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09382246B2
Reaction notes
Loading…